Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor.
Margaret von Mehren, MD on QINLOCK for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor @FoxChaseCancer
By Editor